Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI
Clinical trial NCT07181499 · RECRUITING
Trial details
- NCT number
- NCT07181499
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2028-11-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.